X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1649) 1649
Publication (246) 246
Book Chapter (35) 35
Book Review (20) 20
Conference Proceeding (13) 13
Dissertation (6) 6
Magazine Article (2) 2
Reference (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rimonabant (1546) 1546
animals (876) 876
pyrazoles - pharmacology (669) 669
male (650) 650
piperidines - pharmacology (644) 644
index medicus (598) 598
rats (544) 544
humans (508) 508
pharmacology & pharmacy (501) 501
obesity (453) 453
neurosciences (380) 380
receptor, cannabinoid, cb1 - antagonists & inhibitors (372) 372
mice (335) 335
endocannabinoids (301) 301
endocannabinoid system (257) 257
receptors, cannabinoid (250) 250
dose-response relationship, drug (246) 246
rats, sprague-dawley (201) 201
female (192) 192
cannabinoid (187) 187
cannabinoids (183) 183
receptors, drug - antagonists & inhibitors (183) 183
receptor, cannabinoid, cb1 - metabolism (182) 182
anandamide (181) 181
overweight patients (180) 180
obesity - drug therapy (167) 167
pyrazoles - therapeutic use (165) 165
piperidines - therapeutic use (163) 163
food-intake (161) 161
cannabinoid receptor (157) 157
risk-factors (155) 155
cannabinoids - pharmacology (154) 154
dronabinol - pharmacology (154) 154
psychiatry (152) 152
endocrinology & metabolism (149) 149
article (145) 145
rats, wistar (141) 141
sr141716a (141) 141
antagonist (139) 139
brain (139) 139
cb1 receptor (131) 131
morpholines - pharmacology (131) 131
naphthalenes - pharmacology (130) 130
cb1 (127) 127
cannabinoids - antagonists & inhibitors (121) 121
benzoxazines (106) 106
sibutramine (105) 105
arachidonic acids - pharmacology (103) 103
cb1 receptors (103) 103
orlistat (103) 103
biochemistry & molecular biology (102) 102
metabolic syndrome (102) 102
receptor, cannabinoid, cb1 - agonists (99) 99
cannabinoid-1 receptor blocker (97) 97
activation (95) 95
adult (94) 94
receptor (94) 94
receptor, cannabinoid, cb1 - physiology (93) 93
receptors, drug - metabolism (93) 93
lipids (91) 91
chemistry, medicinal (90) 90
mice, inbred c57bl (89) 89
behavior, animal - drug effects (87) 87
expression (87) 87
piperidines - administration & dosage (87) 87
pyrazoles - administration & dosage (87) 87
receptor, cannabinoid, cb1 - genetics (85) 85
behavioral sciences (84) 84
time factors (84) 84
delta-tetrahydrocannabinol (82) 82
energy-balance (82) 82
cyclohexanols - pharmacology (81) 81
disease models, animal (81) 81
eating - drug effects (81) 81
rat-brain (81) 81
adipose-tissue (80) 80
cannabinoid receptor antagonists - pharmacology (79) 79
cardiometabolic risk-factors (79) 79
inhibition (78) 78
rat (77) 77
risk factors (77) 77
cannabinoid receptors (76) 76
ligands (76) 76
anti-obesity agents - therapeutic use (74) 74
cannabinoid receptor modulators - metabolism (74) 74
cb1 receptor antagonist (74) 74
sr141716 (74) 74
pharmacology (73) 73
sr 141716a (73) 73
weight (73) 73
analysis (72) 72
body-weight (72) 72
receptors (72) 72
receptors, drug - agonists (72) 72
mice, knockout (70) 70
motor activity - drug effects (69) 69
brain - metabolism (68) 68
middle aged (68) 68
receptors, drug - physiology (68) 68
pharmacology/toxicology (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1595) 1595
German (31) 31
French (21) 21
Spanish (11) 11
Chinese (5) 5
Czech (4) 4
Italian (4) 4
Portuguese (4) 4
Hungarian (3) 3
Korean (3) 3
Polish (2) 2
Japanese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 07/2009, Volume 205, Issue 1, pp. 171 - 174
Journal Article
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 09/2010, Volume 13, Issue 8, pp. 1103 - 1113
Journal Article
Inflammation, ISSN 0360-3997, 04/2019, Volume 42, Issue 2, pp. 618 - 627
Sepsis is a life-threatening condition with high mortality rates that is caused by dysregulation of the host response to infection. We previously showed that... 
rimonabant | receptor antagonist | sepsis | organ dysfunction
Journal Article
Pharmacological Research, ISSN 1043-6618, 06/2010, Volume 61, Issue 6, pp. 531 - 536
Increasing evidence suggests a pivotal role of the D3 receptor (D3R) in cognitive processes and the involvement of endocannabinoid/endovanilloid signaling in... 
D3 receptor | Dopamine | receptors | Rimonabant | Memory | TRPV1
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 01/2020, Volume 162, p. 107814
CB1 receptor antagonists disrupt operant responding for food and drug reinforcers, and cue-induced reinstatement of cocaine and heroin seeking. Conversely,... 
MAGL inhibitor | MJN110 | Endocannabinoid | Rimonabant | CB1 receptor | Operant | Incentive cue | Reward predictive cues
Journal Article
Pharmacology Biochemistry and Behavior, ISSN 0091-3057, 12/2012, Volume 103, Issue 2, pp. 425 - 430
CB receptor antagonists proved to be effective anti-obesity drugs, however, their depressive and anxiogenic effects became also evident. Finding solution to... 
Rimonabant | Food intake | Memory | MTEP | Anxiety
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2012, Volume 165, Issue 8, pp. 2479 - 2484
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 06/2009, Volume 29, Issue 11, pp. 2207 - 2216
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2017, Volume 60, Issue 3, pp. 1126 - 1141
We report the design, synthesis, and structure–activity relationships of novel dual-target compounds with antagonist/inverse agonist activity at cannabinoid... 
BLOCKERS | SYSTEM | OBESITY | POTENT | CHEMISTRY, MEDICINAL | RECEPTOR ANTAGONISTS | DRUG DISCOVERY | RESISTANCE | FUTURE | RIMONABANT | DERIVATIVES
Journal Article
International Journal of Obesity, ISSN 0307-0565, 05/2013, Volume 37, Issue 5, pp. 699 - 703
Journal Article
05/2010
Introduction: Obesity has become a public health problem. The increment in energy intake and the reduction of caloric expenditure as a result of sedentary... 
Obesity | Rimonabant | Pharmacotherapy | Orlistat | Sibutramine | Orlistat, Sibutramine, Rimonabant, Obesidad, Farmacoterapia
Web Resource
MOLECULAR PHARMACOLOGY, ISSN 0026-895X, 11/2019, Volume 96, Issue 5, pp. 619 - 628
Cannabinoid receptor 1 (CB1) is a potential therapeutic target for the treatment of pain, obesity and obesity-related metabolic disorders, and addiction. The... 
POTENT | RESIDENCE TIME | MECHANISM | ACCURATE DOCKING | CRYSTAL-STRUCTURE | PHARMACOLOGY | ENDOCANNABINOID SYSTEM | GLIDE | PHARMACOLOGY & PHARMACY | RIMONABANT | SR141716A
Journal Article
by Ji, WJ and Zhao, M and Wang, M and Yan, WH and Liu, Y and Ren, ST and Lu, J and Wang, B and Chen, LN
PLOS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6
Canagliflozin, an inhibitor of sodium glucose co-transporter (SGLT) 2, has been shown to reduce body weight during the treatment of type 2 diabetes mellitus... 
PPAR-ALPHA | SAFETY | DIACYLGLYCEROL ACYLTRANSFERASE-2 DGAT2 | TRIACYLGLYCEROL SYNTHESIS | MULTIDISCIPLINARY SCIENCES | LIVER | DISEASE | RIMONABANT | TYPE-2 DIABETES-MELLITUS | EXPRESSION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.